This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RHOB Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RHOB WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~22.1 kDa | |
| Observed band | Approximately 22 kDa | |
| Gel | 5–20% (catalog A01550-3) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Pathogen-dependent O-glycosylation + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A01550-3 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, rat brain, mouse brain (catalog A01550-3) |
| Gel % | 5–20% (catalog A01550-3) |
| Load | 30 ug; reducing conditions (catalog A01550-3) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A01550-3) |
| Membrane | nitrocellulose membrane (catalog A01550-3) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A01550-3) |
| Primary antibody | A01550-3 · 0.5 μg/mL (catalog A01550-3) |
| Primary incubation | overnight at 4°C (catalog A01550-3) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A01550-3) |
| Secondary incubation | 1.5 hour at RT (catalog A01550-3) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A01550-3) |
| Detection | ECL (catalog A01550-3) |
RHOB is predicted at 22.1 kDa and observed at approximately 22 kDa; the supplied evidence does not establish a cause for their small difference.
| Band at approximately 22 kDa | Matches the reported RHOB band and its 22.1 kDa predicted mass; confirm identity with appropriate controls. |
| Band slightly below the precursor position | Cleavage of the 194–196 propeptide could slightly reduce mass, but a resolvable shift is not established. |
| Little or no band in a soluble fraction | Lipid-anchored RHOB may remain in membrane fractions. |
| Additional band above approximately 22 kDa | Its identity is uncertain; the conditional sugar modifications at Tyr34 and Thr37 do not establish a visible shift. |
| Predicted RHOB mass | 22.1 kDa provides the baseline; the reported band is approximately 22 kDa. |
| Propeptide at residues 194–196 | Cleavage could slightly reduce mass, with no demonstrated resolvable shift. |
| O-linked GlcNAc at Tyr34 by Photorhabdus PAU_02230 | This conditional modification could affect mobility; a visible shift is not established. |
| O-linked Glc at Thr37 by C. difficile toxins TcdA and TcdB | This infection-dependent modification could affect mobility; a visible shift is not established. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Lipid-anchored RHOB may be underrepresented after soluble extraction. | Check a membrane-enriched fraction and an RHOB-positive control. |
| Band higher than expected | The band is unassigned; the listed single-sugar modifications do not establish a visible shift. | Compare with an RHOB depletion control and check infection or toxin exposure. |
| Band lower than expected | Propeptide cleavage can remove residues 194–196, but a distinct lower band is unproven. | Confirm identity by RHOB depletion and assess whether the antibody recognizes the retained sequence. |
| Multiple bands | Their identities are uncertain; the listed modifications do not establish distinct bands. | Compare with RHOB depletion and an independent RHOB antibody. |
| Weak or no signal | Membrane-associated RHOB may be poorly recovered. | Check membrane recovery, sample loading, and a positive control. |
| Fragments below expected size | A distinct fragment is not established by the supplied features. | Check sample integrity and confirm any fragment with RHOB depletion. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for RHOB, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-RHOB polyclonal antibodies have WB images showing an approximately 22 kDa band in the tested lysates. The captions report 30 µg per lane and 0.5 µg/mL primary antibody. No independent specificity validation is supplied.
Which to pick: Both have WB images with human HeLa, rat brain, and mouse brain samples. Choose A01550-1 if monkey COS-7 or rat C6 matches your sample; those examples appear only in its caption. A01550-3 covers the shared tested contexts.